Biomarker test is based on technology developed at WashU Medicine
FDA clears blood test to aid evaluation for Alzheimer’s disease (Links to an external site)
Category: News
Cure Alzheimer’s Fund presents the 2026 Jeffrey L. Morby Prize for Exceptional Research (Links to an external site)
Prize Recognizes Drs. Randall J. Bateman and Kanta Horie of Washington University School of Medicine in St. Louis, and Drs. Oskar Hansson and Gemma Salvadó of Lund University, Sweden
St. Louis researchers receive recognition for groundbreaking Alzheimer’s diagnostic test (Links to an external site)
Washington University professors and C2N Diagnostics co-founders Dr. Randall Bateman and Dr. David Holtzman will receive the 2026 American Innovator Award from the Bayh-Dole Coalition in Washington, D.C., on June 3.
Studying these young Alzheimer’s patients led to breakthroughs. Trump cut the funding (Links to an external site)
Some of the most important studies of potential treatments for Alzheimer’s disease rely on a group of participants who know they may never fully reap the benefits.
These families help scientists find Alzheimer’s treatments. Their network is at risk (Links to an external site)
A network of families riddled with Alzheimer’s has given scientists a unique window on the disease. But the group’s future is uncertain amid funding cuts.
Single Test Could Predict Alzheimer’s Symptoms Before They Even Begin (Links to an external site)
A single blood test may be able to predict when a person will develop Alzheimer’s symptoms—years before memory loss begins—according to new research from the Washington University School of Medicine in St Louis.
Why one man with a genetic predisposition for Alzheimer’s disease is defying the odds (Links to an external site)
Scientists are trying to find out why one man has been able to stave off Alzheimer’s for nearly 25 years despite having a rare genetic mutation that doctors say essentially guaranteed he developed the disease by his late 40s or early 50s.
Promising clinical trials in Alzheimer’s prevention (Links to an external site)
Jake Heinrichs is a Broadway theater electrician from Brooklyn who carries one of the early-onset genes. The disease claimed his grandmother, uncle, father and brother, all within the same age range. “Symptoms in the 40s and, and dying in 50s,” he said.
Promising clinical trials in Alzheimer’s prevention (Links to an external site)
Carrie Richardson, 44, inherited a genetic mutation that caused early-onset Alzheimer’s disease. She’s participating in an Alzheimer’s research study at Washington University School of Medicine.
He Was Expected to Get Alzheimer’s 25 Years Ago. Why Hasn’t He? (Links to an external site)
Scientists are searching for the secret in Doug Whitney’s biology that has protected him from dementia, hoping it could lead to ways to treat or prevent Alzheimer’s for many other people.